methylprednisolone has been researched along with clemastine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Fistarol, SK; Itin, H; Zimmerli, PB | 1 |
| Bas, M; Bier, H; Greve, J; Hoffmann, TK; Kojda, G; Stark, T; Stelter, K | 1 |
| Choy, DF; Hackney, JA; Hogan, VE; Holweg, CT; Kummerfeld, SK; Teng, YK; Townsend, MJ; van Laar, JM | 1 |
| Gaillard, PJ; Gladdines, W; Groeneveld, GJ; Kanhai, KMS; Klaassen, ES; Stavrakaki, I; Zuiker, RGJA | 1 |
1 review(s) available for methylprednisolone and clemastine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 trial(s) available for methylprednisolone and clemastine
| Article | Year |
|---|---|
Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.
Topics: Angioedema; Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Clemastine; Female; Humans; Injections, Subcutaneous; Male; Methylprednisolone; Middle Aged; Retrospective Studies; Time Factors; Treatment Outcome | 2010 |
Glutathione-PEGylated liposomal methylprednisolone in comparison to free methylprednisolone: slow release characteristics and prolonged lymphocyte depression in a first-in-human study.
Topics: Adrenocorticotropic Hormone; Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Blood Glucose; Clemastine; Cross-Over Studies; Delayed-Action Preparations; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Drug Compounding; Drug Therapy, Combination; Female; Glutathione; Healthy Volunteers; Humans; Liposomes; Lymphocyte Count; Male; Methylprednisolone; Osteocalcin; Polyethylene Glycols | 2018 |
3 other study(ies) available for methylprednisolone and clemastine
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
[Multilocular painful urticarial plaques. Eosinophilic cellulitis (Wells syndrome)].
Topics: Adult; Anti-Allergic Agents; Anti-Inflammatory Agents; Biopsy; Cellulitis; Clemastine; Diagnosis, Differential; Drug Therapy, Combination; Eosinophilia; Female; Follow-Up Studies; Humans; Insect Bites and Stings; Methylprednisolone; Skin; Syndrome; Time Factors; Treatment Outcome; Urticaria | 2004 |
Pretreatment synovial transcriptional profile is associated with early and late clinical response in rheumatoid arthritis patients treated with rituximab.
Topics: Acetaminophen; Adult; Antibodies, Monoclonal, Murine-Derived; Antirheumatic Agents; Arthritis, Rheumatoid; Clemastine; Drug Therapy, Combination; Female; Gene Expression Profiling; Health Status; Humans; Immunologic Factors; Male; Methylprednisolone; Middle Aged; Rituximab; Severity of Illness Index; Synovial Membrane; Transcriptome; Treatment Outcome | 2012 |